Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.

Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Published

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.

An abstract is available from the original source but is not redistributed by this database. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal
Neuropharmacology
Date
2018-11-01
Source
PubMed
DOI
10.1016/j.neuropharm.2018.05.012
PubMed
29753748
Record provenance and attribution

The listed authors receive credit for the original research. This tracker aggregates source metadata and derives discovery labels; inclusion is not scientific validation.

Source identifier
Indexed
2026-07-01 06:54:14 UTC
Metadata last checked
2026-08-09 08:28:25 UTC

Checking metadata does not mean individual manual review. Cite the original work for its findings and the exact dataset snapshot and software version for analyses.

Machine-readable provenance

Authors

Watch author

Derived topics and classifications

These labels are search aids derived from indexed metadata, not an assessment of evidence quality. Verify the study design and findings in the original source.

Citation graph

0 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantifying psilocybin exposure in a natural product-based retreat setting: An observational field method for dose measurement2026-12-01A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy Adults2026-09-21The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent Studies2026-08-18Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis2026-07-20Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?2026-07-02Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments2026-06-12Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care2026-05-14Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA2026-05-01Psilocybin use in Puerto Rico: Patterns, motivations, and personality correlates from an online survey2026-04-15Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study2026-02-12Exploring a Decade of Microdosing Research: A Qualitative Meta-synthesis of Microdosing Literature2026-02-09Persistent Altered States: Psychological Treatment of Psychedelic Adverse Effects2025-11-30“It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics2025-10-31Psilocin alleviates acute itch in mice: possible involvement of 5-HT2A receptors and kynurenine pathway2025-10-01Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder2025-09-04Freedom of Recreation: A Critique of the Prohibition, Decriminalization, and Legal Regulation of Psychedelics for Recreational Use2025-08-28The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?2025-08-07Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns2025-07-16University Students’ Motives for Psilocybin Use: A Mixed-Methods Analysis2025-04-26

Related papers

No close related records were found yet.